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In this paper, the link between high glycemic index and load will be reviewed. The data from the literature
discussed relate to a short presentation of the physiopathology of acne, including the influence of
hyperinsulinemia as a key factor at the beginning of acne.
Key teaching points:
N Definition of glycemic index: The glycemic index (GI) is a numerical system of measuring how much of a rise in circulating blood
sugar a carbohydrate triggers.
N Definition of glycemic load: The glycemic load (GL) is a ranking system for carbohydrate content in food portions based on their
glycemic index (GI) and the portion size.
N Definition of acne: Acne is the interplay of 4 factors: 1. hyperkeratinization and obstruction of sebaceous follicles; 2/ androgen-
stimulated increase in sebum production; and 3. colonization of the follicles by Propionibacterium acnes.
N Definition of IGF-1: Insulin-like growth factor 1 (IGF-1), which was once called somatomedin C, is a polypeptide protein hormone
similar in molecular structure to insulin.
N Definition of IGFBP-3: Insulin-like growth factor binding protein 3, also known as IGFBP3, is a protein which in humans is
encoded by the IGFBP3 gene, a member of the insulin-like growth factor binding protein (IGFBP) family.
ACNE
Acne is a common but complex skin disease that affects
individuals of all ages. In the Western world, acne is estimated
to affect 79% to 95% of the adolescent population, 40% to 54%
of individuals older than 25 years, and 12% of women and 3% of
men of middle age [1]. On the contrary, acne remains rare in
non-Westernized societies such as among the Inuit [2],
Okinawan Islanders [3], Ache hunter-gatherers, and Kitavan
Islanders [1]. Although familial and ethnic factors are
implicated in acne prevalence, recent data indicate that the
incidence of the disease has increased with the adoption of
Western lifestyles [2]. These observations suggest that lifestyle,
including diet and in particular its glycemic index (GI) and
glycemic load (GL), may be involved in acne pathogenesis [4].
Even if the relationship between GI, GL, and acne is
controversial, recent randomized controlled trials showed an
improvement in acne after GI and GL were reduced [4–7]. In
contrast, Kaymak et al. [8] did not find that dietary GI, GL, and
insulin level have a role in the pathogenesis of acne in young
patients. The limitation of this last study was that the dietary
data were obtained via a dietary questionnaire based on
patients’ own recollection of intake.
The relationship of acne to foods is certainly not new. Many
textbooks of dermatology [9–11] published in the early 1950s
contained information regarding specific foods to be avoided to
prevent acne. Advice to avoid chocolate, fats, sweets, and
carbonated beverages was commonly given to patients as part of
acne therapy. However, this dietary advice has been removed
from more recent textbooks, and no restriction of specific foods
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has been recommended to patients. It should be noted, however,
that it was reported in a recent article [12] that many patients
believe that acne is influenced by diet.
Acne is thought to result from the interplay of 3 factors: (1)
hyperkeratinization and obstruction of sebaceous follicles
caused by abnormal desquamation of the follicular epithelium;
(2) androgen-stimulated increase in sebum production; and (3)
colonization of the follicle by Propionibacterium acnes, which
generates inflammation [13,14]. The ultimate mechanisms
responsible for factors 1 and 2 are not well understood [14,15].
It is likely that any environmental element underlying the
development of acne must operate via modulation of the
known proximate or ultimate (genetic) causes.
DIET, HYPERINSULINEMIA, AND ACNE
Although diet is infrequently considered as a causative
agent in the development of acne [16], it represents a well-
recognized factor in acute [17] and chronic [18,19] hyper-
insulinemia. Recent evidence has demonstrated that the
hormonal cascade triggered by diet-induced hyperinsulinemia
elicits an endocrine response that simultaneously promotes
unregulated tissue growth and enhanced androgen synthesis
[5,6,8]. Hence, hyperinsulinemic diets may represent a
previously unrecognized environmental factor in the develop-
ment of acne, as is described in the following paragraphs.
Hyperinsulinemia and Free IGF-1 and IGFBP-3
Chronic and acute hyperinsulinemia initiate a hormonal
cascade that favors unregulated tissue growth by simulta-
neously elevating the levels of free insulin-like growth factor 1
(IGF-1) and reducing the levels of insulin-like growth factor
binding protein 3 (IGFBP-3) [20–23]. Because free IGF-1 is a
potent mitogen [24], elevated concentrations of free growth
factor have the potential for stimulating growth in tissues,
including the follicle.
It is well known that IGF-1 in humans is required for
keratinocyte proliferation [25], and that in transgenic mice,
overexpression of IGF-1 results in hyperkeratosis and epidermal
hyperplasia [26]. These data support the possible idea that
insulin-trigged elevation in free IGF-1 levels may promote acne
via skin hyperkeratinization. Furthermore, women with post-
adolescent acne maintain elevated serum concentrations of IGF-
1 [27] and are mildly insulin resistant [28].
The reductions in IGFBP-3 levels stimulated by elevated
serum insulin [20,21] or by acute ingestion of high glycemic
load carbohydrates [29] also may contribute to unregulated cell
proliferation in the follicle. In fact, in murine knockout cells
lacking the IGF receptor, IGFBP-3 acts as a growth inhibitory
factor [30]. IGFBP-3 inhibits growth by preventing IGF-1 from
binding to its receptor. Moreover hyperinsulinemia induces
production of transforming growth factor beta-1 [31]. In-
creased concentrations of this and other cytokines depress
localized keratinocyte synthesis of IGFBP-3, thereby increas-
ing the availability of free IGF-1 to its keratinocyte receptors
[31], which, in turn, promotes keratinocyte proliferation.
Consequently, hyperkeratinization of sebaceous follicles may
result synergistically from elevations in free IGF-1 levels and/
or reductions in concentrations of IGFBP-3.
IGFBP-3 and Retinoid Receptors
Insulin-mediated reductions in IGFBP-3 levels may further
promote unregulated follicular growth by affecting the nuclear
retinoid signaling pathway. Retinoids are natural and synthetic
analogues of vitamin A that inhibit cell proliferation and
promote apoptosis [32]. The natural retinoids (trans retinoic
acid and 9-cis-retinoic acid) of the body act by binding 2
families of nuclear receptors: retinoic acid receptors (RARs)
and retinoid X receptors (RXRs). Retinoid receptors, in turn,
activate gene transcription by binding as RAR-RXR hetero-
dimers or RXR-RXR homodimers to retinoic acid response
elements located in the promoter regions of target genes,
whose function is to limit growth in many cell types [33].
IGFBP-3 is also a ligand for the RXR alpha nuclear
receptor and enhances RXR-RXR homodimer mediated
signaling [34]. As has been shown in knockout rodents, the
RXR alpha gene is required for actions of the 2 endogenous
retinoic acid ligands [35,36]. RXR alpha is the major RXR
receptor in the skin [37], and together with IGFBP-3, is growth
inhibitory in many cell lines [38]. Additionally, low plasma
levels of IGFBP-3 induced by hyperinsulinemia may reduce
the effectiveness of the natural retinoids of the body to activate
genes that normally would limit follicular cell proliferation.
Hyperinsulinemia, IGF-1, Androgenesis, and
Sebum Production
Sebum production is stimulated by androgens [13,14], also
as a consequence of the well-established androgenic effect of
hyperinsulinemia. In fact, insulin and IGF-1 stimulate the
synthesis of androgens in ovarian [39,40] and testicular [41,42]
tissues. Moreover, insulin and IGF-1 inhibit the hepatic
synthesis of sex hormone binding globulin (SHBG) [43,44].
Cross-sectional studies demonstrate inverse relationships
between serum SHBG, insulin [45], and IGF-1 [46–48]. Direct
injections of recombinant IGF-1 in humans elicit androgenesis
and acne [49]. Higher serum androgen [50], insulin [27], and
IGF-1 [28] concentrations in women are associated with the
presence of acne. Taken together, these data suggest that the
endocrine cascade induced by hyperinsulinemia enhances
sebum synthesis and acne development.
The role of insulin is also supported by the high prevalence
of acne in women with polycystic ovary syndrome (PCOS), a
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condition associated with insulin resistance, hyperinsulinemia,
and hyperandrogenism [51]. Insulin resistance may be
correlated with the underlying disturbance in PCOS, where
elevated IGF-I concentrations and low SHBG levels are found
[52]. Recently, based on this view, the treatments for PCOS
now include oral hypoglycemic agents [53].
DIETARY INTERVENTION STUDIES
In spite of the above-mentioned evidence, few well-
controlled dietary studies have examined the effects of diet
on acne. Fulton et al. [54], in a crossover, single-blind study,
found no effect of chocolate on acne when compared with a
placebo bar. However, later examination of the ingredients in
the placebo indicated that its composition was virtually
identical to that of the chocolate [55]. Anderson examined
the effects of daily consumption of chocolate, milk, or nuts and
found no effects [56]. However, this study has been criticized
for its small sample size, short follow-up, and lack of control
[57]. Chiu et al. [58] showed an association between worsening
diet quality and exacerbation of acne during a preexamination
period. However, stress was found to be the main contributing
factor, and the diet was assessed with the use of nonscientific
methods. Recently, a retrospective evaluation of dietary intake
showed a positive association between milk consumption and
severe acne [59].
Cordain et al. [1] postulated that high glycemic load diets
may be a significant contributor to the high prevalence of acne
seen in Western countries. The authors suggest that frequent
consumption of high GI carbohydrates may repeatedly expose
adolescents to acute hyperinsulinemia. Therefore, a low
glycemic load diet may have a therapeutic effect on acne
related to the beneficial endocrine consequences of these diets.
This hypothesis was based on the fact that high glycemic load
diets may influence 1 or more of the 4 underlying causes of
acne mentioned above [29]. A different conclusion was
reached by Kaymak et al. [8], who found that glycemic index,
glycemic load, and insulin levels in younger patients do not
have a role in the pathogenesis of acne. However, again the
evaluation of the diet was made on the basis of a voluntary
self-completed questionnaire. In a more recent study [6], the
effects of a low glycemic load diet on acne and the fatty acid
composition of skin surface triglycerides were evaluated. Total
acne lesions and inflammation were dramatically decreased in
the treated subjects. The new finding was noted after the fatty
acid of the skin surface triglyceride was analyzed. In fact, the
subject of the low glycemic load diet group demonstrated an
increase in the ratio of saturated fatty acids (in particular,
palmitic acid) versus monounsaturated fatty acids (in parti-
cular, C16:1), thereby suggesting a decrease in the enzymatic
desaturation of C16:0 in the treated group. Worthy of note, the
enzyme delta-6 desaturase, which is responsible for converting
palmitic acid into the monounsaturated sapienic fatty acid
(16:1), is unique and characteristic of human sebaceous glands.
Taken together, the data presented by Smith et al. [6] suggest a
possible role of desaturase enzymes in sebaceous lipogenesis
and the clinical manifestation of acne. However, further work
is needed to clarify the underlying role of diet, and in particular
of the low glycemic index and low glycemic load diet, in
sebum gland physiology.
CONCLUSION
To our knowledge, the studies of Smith et al. [4,7]
published in 2007 are the first studies to show a therapeutic
effect of dietary intervention on acne. After 12 weeks, the low
glycemic load diet was shown to significantly reduce lesion
counts and improve insulin sensitivity when compared with a
high glycemic load diet. Although the authors could not isolate
the effects of the low glycemic load diet from those of weight
loss, their findings are consistent with earlier suggestions of
the association between hyperinsulinemia and acne, as were
already mentioned. Moreover, Smith et al. [5,6] supported
these findings in 2 articles published in 2008. In these papers, a
new hypothesis was proposed: that diet may influence the skin
surface triglyceride, which in turn may be related to acne
pathogenesis. However, these observations remain to be
substantiated and the underlying mechanisms determined in
larger scale studies.
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